Worldwide dental implants are poised to achieve significant growth as patients
become aware of the health benefits achieved from having viable teeth. Dental
implants are in the category of optional surgery and represent the type of consumer
spending that is postponed in challenging economic environments. The companies
participating in the dental implant market have found ways to manage infection,
providing a higher implant success rate. Implantable devices are more stable
in the mouth, permitting fewer dental implant failures.
69% of adults ages 35 to 44 have lost at least one permanent tooth to an accident,
gum disease, a failed root canal, or tooth decay. By age 74, 26% of adults have
lost all of their permanent teeth. With the number of Americans over 55 growing
by 60% in the next 20 years there is plenty of U.S. market opportunity. The
baby boomer generation buying power exceeds $2 trillion in 2009.
The leading six dental implant manufacturers control of the market is based
on the need for marketing in this segment, with Nobel Biocare holding the number
one market position and Straumann holding a share of almost one-fifth and ranking
as the firm number-two player. A large number of small manufacturers earlier
accounting for a third of the market have shrunk to 14% of it.
Dental implant market innovations are those that position the vendor companies
to meet aesthetic demands and increase clinician productivity. Positioning for
profitable business patient care delivery can be challenging for clinicians.
Tooth loss, gum and bone disease affect millions of people worldwide, on every
continent, in every age group. Globally, several hundred million people are
missing one or more teeth. More than 40 million people are fully edentulous
in the Western developed world. These numbers are substantially higher in Asia,
Africa and other parts of the world.
For 2008 the global dental implant market was 2.3 billion Euros. The market
for crowns and bridges is 3 billion Euros. These estimates size the opportunity
of the global restorative and esthetic dentistry market. Nobel Biocare is the
clear market leader in this market.
The outlook for 2009 is one of a demanding market environment. Deteriorating
economic conditions in most markets continue to impact dental implant markets
because consumers have less discretionary income. Visibility in economic recovery
time remains low.
Nanotechnology Impacts The Dental Implant Market
One of the most active and important current areas of research and application
of nanotechnology is in the field of life sciences and healthcare. Many industry
and business analysts now expect nanotechnology to revolutionize the pharmaceutical,
medical devices, diagnostics and imaging sectors with annual markets of billions
of pounds likely within five-ten years.
According to Susan Eustis, lead author of the study, "Nanotechnology has
begun to impact the dental implant market in a dramatic manner. By increasing
the complexity of the surface topography with the addition of nano-scale calcium
phosphate (CAP) crystals new capabilities are available to clinicians. Surface
topography plays a determinant role in the bone bonding phenomenon."
Smaller market participants are active in their national markets and compete
mainly on price, with limited investments in R&D, training, education, marketing
and sales. In countries like Brazil, Russia and India these companies hold over
50% of the market. With the Internet evolving as a channel, larger participants
gain market visibility and strategic advantage on return on investment for the
dentist. Expanding use of dental implants by dental surgeons and general practitioners
indicates a growth market as soon as consumer confidence is stabilized.
Markets for dental implants at $3.4 billion in 2008 are anticipated to reach
$8.1 billion by 2015, growing in response to demand for better teeth worldwide.
The technology is achieving a maturity level that makes the implants last longer
and work in a more reliable manner, stimulating demand from an aging population.
This market is poised for rapid growth as soon as the global economy recovers.
The technology is more mature, leading to implants that last longer.